Showing 101 - 120 results of 125,044 for search '(((( c largest decrease ) OR ( ((a large) OR (b large)) decrease ))) OR ( 1 levels increased ))*', query time: 2.51s Refine Results
  1. 101
  2. 102
  3. 103

    Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
  4. 104

    Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    Fig 3 - by Olaf Nickel (9524791)

    Published 2022
    Subjects:
  10. 110

    Fig 6 - by Olaf Nickel (9524791)

    Published 2022
    Subjects:
  11. 111

    Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

    Published 2023
    “…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”
  12. 112
  13. 113

    Metabolites with increasing levels during the development. by Martin Sládek (130663)

    Published 2025
    “…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly increasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”
  14. 114

    Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

    Published 2021
    “…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
  15. 115
  16. 116

    (a) Measuring device; (b) Measuring method. by Chenhao Li (822769)

    Published 2025
    “…Although increasing SHMP content improved the early strength, it led to a decrease in later strength, with the maximum late strength observed at 2% SHMP. …”
  17. 117
  18. 118
  19. 119
  20. 120